| Dr Danielle Dionne Mercer, AUD | |
|
533 Bolivar St Rm 659, New Orleans, LA 70112-1349 | |
| (504) 568-2435 | |
| Not Available |
| Full Name | Dr Danielle Dionne Mercer |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 533 Bolivar St Rm 659, New Orleans, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265970644 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 7357 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Danielle Dionne Mercer, AUD 533 Bolivar St Rm 659, New Orleans, LA 70112-1349 Ph: (504) 568-2435 | Dr Danielle Dionne Mercer, AUD 533 Bolivar St Rm 659, New Orleans, LA 70112-1349 Ph: (504) 568-2435 |
News Archive
Saint-Gobain Performance Plastics has expanded its line of thermoplastic elastomer (TPE) tubing with the addition of new C-Flex® ULTRA pump tubing, a product designed specifically to perform in demanding biopharmaceutical applications such as pumping, single-use assemblies, process filling and sampling.
Recent studies have identified many genes that may put people with schizophrenia at risk for the disease. But, what links genetic differences to changes in altered brain activity in schizophrenia is not clear. Now, three labs at the Perelman School of Medicine at the University of Pennsylvania have come together using electrophysiological, anatomical, and immunohistochemical approaches - along with a unique high-speed imaging technique - to understand how schizophrenia works at the cellular level.
eHealth/Commonwealth Fund: National Progress Report On eHealth - This extensive report examines changes in the adoption and use of health information technology (HIT) since 2007, as assessed by a group of more than 100 experts.
Bayer has announced that a Phase III trial evaluating its oncology compound Stivarga® (regorafenib) tablets for the treatment of patients with unresectable hepatocellular carcinoma (HCC) has met its primary endpoint of a statistically significant improvement in overall survival. The study, called RESORCE, evaluated the efficacy and safety of regorafenib in patients with HCC whose disease has progressed after treatment with sorafenib. The safety and tolerability were generally consistent with the known profile of regorafenib. Detailed efficacy and safety analyses from this study are expected to be presented at an upcoming scientific congress.
› Verified 3 days ago
Vaughn Johnson Davis, AUD, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4301 Tulane Ave Apt 275, New Orleans, LA 70119 Phone: 504-296-4834 | |
Miss Christine Elizabeth Gibson, M.C.D., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 6260 Providence Pl, New Orleans, LA 70126 Phone: 504-957-7762 | |
Dr. Erica Cardosi, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 1900 Gravier St, New Orleans, LA 70112 Phone: 504-568-4343 | |
Mrs. Kristen Schexnayder, M.C.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 120 N Jefferson Davis Pkwy, New Orleans, LA 70119 Phone: 504-821-0244 | |
Elizabeth Nichole Brown, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-4565 | |
Dr. Madden Elizabeth Wilbert, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 866-624-7637 |